BEIJING--(BUSINESS WIRE)--Oct 26, 2023--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase III registrational trial of the CompanyÄ¢¹½ÊÓÆµ BTK ...
SAN DIEGO--(BUSINESS WIRE)--Oct 26, 2023--Fore Genomics, Inc. announced the launch of its revolutionary FORESITE 360â„¢ service using whole genome sequencing (WGS) today, which gives you a complete map (100%) of your babyÄ¢¹½ÊÓÆµ DNA with a simple at-home collection kit. FORESITE 360â„¢ is a 100% ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 26, 2023--Foundation Medicine, Inc., today announced its participation in the National Cancer InstituteÄ¢¹½ÊÓÆµ (NCI) Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH) initiative to test new therapy combinations in ...
NYON, Switzerland--(BUSINESS WIRE)--Oct 26, 2023--Edwards Lifesciences today announced it received CE Mark for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position. The MITRIS RESILIA valve is made with innovative bovine pericardial tissue ...
LOWELL, Mass.--(BUSINESS WIRE)--Oct 25, 2023--RevBio, Inc., announced that it has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or <a ...